Abstract:γ-aminobutyric acid type A receptors (GABAARs) are the major mediators of synaptic inhibition in the brain. Aberrant GABAAR activity or regulation is observed in various neurodevelopmental disorders, neurodegenerative diseases and mental illnesses, including epilepsy, Alzheimer's and schizophrenia. Benzodiazepines, anesthetics and other pharmaceutics targeting these receptors find broad clinical use, but their inherent lack of receptor subtype specificity causes unavoidable side effects, raising a need for new or adjuvant medications. In this review article, we introduce a new strategy to modulate GABAeric signaling: targeting the intracellular protein interactors of GABAARs. Of special interest are scaffolding, anchoring and supporting proteins that display high GABAAR subtype specificity. Recent efforts to target gephyrin, the major intracellular integrator of GABAergic signaling, confirm that GABAAR-associated proteins can be successfully targeted through diverse molecules, including recombinant proteins, intrabodies, peptide-based probes and small molecules. Small-molecule artemisinins and peptides derived from endogenous interactors, that specifically target the universal receptor binding site of gephyrin, acutely affect synaptic GABAAR numbers and clustering, modifying neuronal transmission. Interference with GABAAR trafficking provides another way to modulate inhibitory signaling. Peptides blocking the binding site of GABAAR to AP2 increase the surface concentration of GABAAR clusters and enhance GABAergic signaling. Engineering of gephyrin binding peptides delivered superior means to interrogate neuronal structure and function. Fluorescent peptides, designed from gephyrin binders, enable live neuronal staining and visualization of gephyrin in the post synaptic sites with submicron resolution. We anticipate that in the future, novel fluorescent probes, with improved size and binding efficiency, may find wide application in super resolution microscopy studies, enlightening the nanoscale architecture of the inhibitory synapse. Broader studies on GABAAR accessory proteins and the identification of the exact molecular binding interfaces and affinities will advance the development of novel GABAAR modulators and following in vivo studies will reveal their clinical potential as adjuvant or stand-alone drugs.

Neuroactive Steroids and Human Recombinant Ρ1 GABA Receptors

Inhibitory Actions of Potentiating Neuroactive Steroids in the Human α1β3γ2L γ-Aminobutyric Acid Type A Receptor

Inhibitory Actions of Potentiating Neuroactive Steroids in the Human {alpha}1{beta}3{gamma}2L {gamma}-Aminobutyric Acid Type A Receptor

Divergent mechanisms of steroid inhibition in the human ρ1 GABAA receptor

Divergent mechanisms of steroid inhibition in the human ρ1 GABA receptor

Stable High Expression of Human Gamma-Aminobutyric Acida Receptors Composed of Alpha and Beta Subünits

Differential Responses of Expressed Recombinant Human Γ‐aminobutyric AcidA Receptors to Neurosteroids

Differential Responses of Expressed Recombinant Human ?-Aminobutyric Acid<sub>A</sub> Receptors to Neurosteroids

Effect of Steroid on Binding Properties of Glycine Receptors on Synaptic Plasma Membrane from Rats

Forty Years Searching for Neurosteroid Binding Sites on GABAA Receptors

Neuroactive Type-A γ-Aminobutyric Acid Receptor Allosteric Modulator Steroids from the Hypobranchial Gland of Marine Mollusk, Conus geographus

The Channel-Lining 6′ Amino Acid in the Second Membrane-Spanning Region of Ionotropic GABA Receptors Has More Profound Effects on 4′-Ethynyl-4- N -Propylbicycloorthobenzoate Binding Than the 2′ Amino Acid

Effects of Neurosteroid and Benz[e]indene Enantiomers on GABAA Receptors in Cultured Hippocampal Neurons and Transfected HEK-293 Cells

3 β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield

Heteromeric GABA<sub>A</sub>receptor structures in positively-modulated active states

Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism

Heteromeric GABAA receptor structures in positively-modulated active states

Comparison of Behavioral Effects of GABAergic Low- and High-Efficacy Neuroactive Steroids in the Zebrafish Larvae Assay

GABAA receptor cysteinyl mutants and the ginkgo terpenoid lactones bilobalide and ginkgolides

Targeting GABAAR-Associated Proteins: New Modulators, Labels and Concepts

GABAA Receptor Open-State Conformation Determines Non-Competitive Antagonist Binding.